glp-1 and gip/glp-1 receptor agonists Targeting GLP-1, GIP & GCG in Obesity Type 2 Diabetes Research Alimentary Pharmacology & Therapeutics |

no major safety concerns were observed

Preclinical studies have confirmed that GIPRGLP1R coagonists improve several hallmarks of metabolic syndrome, such as obesity, hyperglycemia, and dyslipidemia

India stands tall as the worlds pharmacy now poised to lead the GLP-1 revolution

In response to shortages, the FDA allowed use of compounded GLP-1 drugs. What are “compounded drugs? Most prescription medications are approved by the FDA and manufactured by drug companies.Compoundeddrugs are made by licensed pharmacists or physicians who […]

It also encourages feelings of fullness, which can help reduce cravings and support consistent, long-term wellness as part of a balanced lifestyle

The hypothesis posits that a systems-based review of GLP-1 RA mechanisms will reveal positive and negative effects across multiple organ systems, providing comprehensive insights into the hormone's physiological impact.This systematic review will assess the appropriateness of GLP-1 RAs in various aforementioned patient health states, shedding light on their potential impacts on comorbidities